ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
11 May 2023

Acarix AB (publ) publishes Interim Report, January – March 2023

2023 is off to a good start In the first quarter of 2023 our strategy delivered important results with a breakthrough order from the la...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Apr 2023

Acarix AB’s Annual Report 2022

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces that the Annual Report for 2022 is available as a pdf on...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Apr 2023

Acarix AB’s Årsredovisning 2022

Acarix, ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att årsredovisning för 2022 finns tillgänglig som pdf på bol...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Feb 2023

Acarix AB (publ) publicerar Bokslutskommuniké 2022

Strategiskt skifte till fullt kommersiellt fokus på USA-marknaden nu på plats När vi summerar 2022 blir det tydligt att Acarix på kort ...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Feb 2023

Acarix AB (publ) publishes Year-End Report 2022

Strategic shift towards full commercial focus on the US market now in place As we sum up 2022, it becomes clear that Acarix has in a sh...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Nov 2022

Full focus on the US market with strong interest from healthcare providers, reimbursement code in place and collaboration with ACC

Acarix is now taking an important strategic step, putting full commercial focus on the US market. We have the key building blocks in pl...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Nov 2022

Fullt fokus på USA med stort intresse från sjukvården, egen reimbursementkod på plats och samarbete med ACC

Acarix tar nu ett viktigt strategiskt kliv och lägger fullt kommersiellt fokus på USA-marknaden. Vi har de viktiga byggstenarna på plat...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Aug 2022

Acarix AB (publ) publishes Interim Report, January – June 2022

Significant interest and positive developments in the US market We can now conclude that our Go-To-Market strategy in the USA has start...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Aug 2022

Acarix AB (publ) publicerar delårsrapport, januari – juni 2022

Stort intresse och positiv utveckling på den amerikanska marknaden Vi kan nu konstatera att vår Go-To-Market strategi i USA börjat gene...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2022

Acarix AB (publ) publicerar delårsrapport, januari – mars 2022

Pressmeddelande Malmö, 11 maj 2022   Acarix AB (publ) publicerar delårsrapport, januari - mars 2022 Ökat momentum i verksamheten och ...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2022

Acarix AB (publ) publishes Interim Report, January – March 2022

Press release Malmö, Sweden, May 11, 2022   Acarix AB (publ) publishes Interim Report, January – March 2022 Increased commercial mome...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Apr 2022

Acarix publishes the annual report for 2021

Press release Malmö, Sweden, April 20, 2022   Acarix publishes the annual report for 2021 Today, Wednesday April 20, Acarix is publis...
Continue reading
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.